Financial News

  • Pace of Medtech M&A Activity Not Likely to Abate in 2017

    Pace of Medtech M&A Activity Not Likely to Abate in 2017

    Predicting the future can be risky and fraught with difficulty, especially in the healthcare sector. A myriad of unforeseen factors can affect outcomes, botching even the most conservative of forecasts. Some prophecies have better odds than others…
    Mark Bonifacio, Founder and President, Bonifacio Consulting Services 03.22.17

  • Trump’s 100-Day (Plus) Plan for Medtech M&A

    Trump’s 100-Day (Plus) Plan for Medtech M&A

    Amid much pomp and circumstance, Donald J. Trump has been officially sworn in as the 45th U.S. president, bringing an end to the most inconceivable election cycle in modern history. As Trump’s reign begins, pundits, economists, and ordinary Ame…
    Bryan Hughes, Director, P&M Corporate Finance 02.23.17

  • Setting Transaction Process Expectations: Strategic vs. Financial Buyers

    Setting Transaction Process Expectations: Strategic vs. Financial Buyers

    Much time has been spent analyzing M&A and consolidation trends impacting the medical device and manufacturing industries, and rightfully so. As transaction multiples remain strong and high-quality and well-heeled buyers continue to execute aggre…
    Brian Gorski, Vice President, P&M Corporate Finance 11.22.16

  • The Zimmer-Biomet Deal—Has it Really

    The Zimmer-Biomet Deal—Has it Really 'Shaken' Warsaw?

    It’s hard to believe that it’s been more than two years since a series of major acquisitions swept across the medical technology landscape during the first six months of 2014. In April that year, Zimmer Holdings Inc. announced the acquisi…
    Bryan Hughes, Director, P&M Corporate Finance 09.20.16

  • Foretelling the Year in Medtech Finance

    Foretelling the Year in Medtech Finance

    To celebrate its 80th birthday in September 1931, The New York Times asked Henry Ford and seven other American trailblazers to envision life eight decades into the future. Some of the prophecies were quite amusing. Ford speculated that Americans w…
    Michael Barbella, Managing Editor 02.17.16

  • Medtech Supplier Consolidation, the Boeing Way

    The parallels are uncanny, to say the least. Nearly two decades ago, Boeing’s then-bungling but otherwise brilliant CEO embarked on a radical cost-cutting mission to help the global aerospace giant (empowered by its 1997 merger with struggling…
    Michael Barbella, Managing Editor 11.17.15

  • Hip Recall Charges No Longer Weighing Down Stryker’s Earnings

    Declining hip implant recall expenses and surging neurotechnology and spinal device sales helped Stryker Corp.’s earnings rebound dramatically in the second quarter of 2015. The Kalamazoo, Mich.-based orthopedic manufacturing behemoth report…

  • Idinvest Partners Funnels 3.2M Euros Into Safe Orthopaedics

    Safe Orthopaedics, a developer of sterile implants and single-use instruments for back surgery, has secured 3.2 million euros (roughly $3.6 million) in financing from investment funds managed by Idinvest Partners. The company intends to use the pr…

  • NuVasive Extends its Earnings Hot Streak

    San Diego, Calif.-based spine firm NuVasive Inc. posted solid second-quarter results and reported the conclusion of an ongoing investigation by the U.S. Department of Justice. For the second quarter of FY15 (ended June 30), the company reported to…

  • DJO Sales Decline Slightly in Q2, Surgical Implant Sales Up 12 Percent

    San Diego, Calif.-based DJO Global Inc. has released financial results for its second quarter (ended June 27). The quarter achieved net sales of $310.8 million, reflecting a decline of 1 percent, compared with net sales of $313.9 million for the s…

  • The Dodd-Frank Act at 5: Nary a Nay to Exorbitant CEO Pay

    The controversy is not at all surprising. In fact, the global debate is precisely the kind of fallout Daniel Price expected from his groundbreaking decision this past spring. The Gravity Payments CEO reopened old pay disparity wounds and exacerbated…
    Michael Barbella, Managing Editor 08.05.15

  • Global Solutions to Bringing Salaries Back to Earth

    There apparently are limits to human opulence, even in America. Incredibly, the nation that long flaunted its “bigger is better” tenet with mile-high skyscrapers, gas-guzzling SUVs, McMansions, megamalls and giant superstores may finally…
    Michael Barbella , Managing Editor 08.05.15

  • Going to Bat for Medtech Innovation

    Forget the lightbulb. Thomas Edison’s greatest invention may be that of the lone innovator. Legend has long hailed Edison as the patron saint of electric light, giving him full credit for banishing world darkness through marathon trial-and-error…
    Michael Barbella , Managing Editor 05.27.15

  • Greatbatch’s Q4 Earnings Outperform Analysts’ Estimates

    For the fourth quarter, Greatbatch Inc. beat earnings estimates but fell a little short in revenue. The company recorded adjusted earnings per share (EPS) of 65 cents in the fourth quarter of 2014, which beat analysts’ estimates by 6 cents and…

  • For 2014, LDR Grew Revenue by Double Digits

    LDR Holding Corporation turned in a solid performance in 2014. For the year ended Dec. 31, 2014, LDR’s total revenues grew 26.6 percent to $141.3 million, with proceeds from the company’s exclusive technology products swelling 35.2 perce…

  • Integra LifeSciences Recorded Solid Gains in 2014 Sales

    Integra LifeSciences Holdings Corporation ended 2014 on a very positive note. The company reported adjusted earnings per share (EPS) of 94 cents in the fourth quarter of 2014, up 13.3 percent compared with Q4 2013. Adjusted results beat the Zacks Co…

  • Inversions, IPOs and Integration: The Year in Medtech Finance

    The difficulty about living backwards and thinking forwards is that you become confused about the present. It is also the reason why one prefers to escape into the abstract.” — T.H. White, “The Book of Merlyn” The irony…
    Michael Barbella, Managing Editor 12.01.14

  • NuVasive Revenues Surge 15 Percent in Second Quarter

    NuVasive Inc.’s latest earnings report topped analysts’ expectations. The San Diego, Calif.-based company reported second-quarter revenues increased 15.1 percent to $190.68 million from $165.70 million in the same quarter last year,…

  • Zimmer’s Second-Quarter Net Income Jumps 16 Percent Zimmer Holdings Inc. reported a 16 perc

    Zimmer’s Second-Quarter Net Income Jumps 16 Percent Zimmer Holdings Inc. reported a 16 percent increase in second-quarter net income, but the surgical product maker lowered the top end of its 2014 earnings forecast. The Warsaw, Ind.-based…

  • Jonathan Safran Foer could feel the frustration mounting within him.

    CEO Pay Increasingly Tied to Company Performance